Strand Life Sciences, a subsidiary of Reliance Industries Limited, today announced the grant of an Indian patent covering its ...
Source matters: Performance of guideline-anchored RAG versus broad evidence LLMs in GI oncology. This is an ASCO Meeting Abstract ...
PolyPEPI1018 Cancer Vaccine and TAS-102 for Patients With Advanced, Chemo-Refractory, Microsatellite-Stable Metastatic Colorectal ...
Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results